Variant report
Variant | nsv983047 |
---|---|
Chromosome Location | chr11:83687828-83689052 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs542000348 | chr11:83687837-83687838 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs140194558 | chr11:83687844-83687845 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs143920652 | chr11:83687850-83687851 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs557977300 | chr11:83687852-83687853 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs35863755 | chr11:83687863-83687864 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs12289688 | chr11:83687873-83687874 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
7 | rs184734437 | chr11:83687908-83687909 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs12808113 | chr11:83687910-83687911 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
9 | rs12808131 | chr11:83687941-83687942 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
10 | rs546061780 | chr11:83687992-83687993 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs561948429 | chr11:83688053-83688054 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs529168156 | chr11:83688106-83688107 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs376854922 | chr11:83688110-83688111 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs556300029 | chr11:83688140-83688141 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs369060474 | chr11:83688256-83688257 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs531717001 | chr11:83688276-83688277 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs556251900 | chr11:83688292-83688293 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs541999695 | chr11:83688307-83688308 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs188622054 | chr11:83688320-83688321 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs116109713 | chr11:83688377-83688378 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs552383614 | chr11:83688396-83688397 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs112919431 | chr11:83688418-83688419 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs2514147 | chr11:83688582-83688583 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
24 | rs534685054 | chr11:83688623-83688624 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs553363763 | chr11:83688624-83688625 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs150023387 | chr11:83688719-83688720 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs180670915 | chr11:83688751-83688752 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs183601670 | chr11:83688776-83688777 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs575390794 | chr11:83688787-83688788 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs71465583 | chr11:83688881-83688882 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
31 | rs557547854 | chr11:83688882-83688883 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs572929143 | chr11:83688897-83688898 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs539967985 | chr11:83688927-83688928 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs527744322 | chr11:83688934-83688935 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs188348158 | chr11:83688943-83688944 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs547628387 | chr11:83688982-83688983 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs570631623 | chr11:83689022-83689023 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs562813355 | chr11:83689043-83689044 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs532981283 | chr11:83689050-83689051 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Medulloblastoma | 21979893 | CNVD |
Gastric cancer | 17908304 | CNVD |
Multiple myeloma | 20724749 | CNVD |
Wilms tumour | 21544195 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Intellectual disability | 22102821 | CNVD |
Autism | 22495311 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Cancer | 21637783 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Chronic lymphocytic leukemia | 21795749 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Neuroblastoma | 21484798 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Oral cancer | 21386901 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 20837533 | CNVD |
Breast cancer | 21264507 | CNVD |
Cervical cancer | 21063398 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Liposarcoma | 21253554 | CNVD |
Neuroblastoma | 18923524 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Multiple myeloma | 16461302 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Cancer | 16751803 | CNVD |
Seminomas | 18059402 | CNVD |
Cervical cancer | 21062161 | CNVD |
Prostate cancer | 18632612 | CNVD |
Breast cancer | 17899364 | CNVD |
Breast cancer | 17157792 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Cancer | 22429812 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
Breast cancer | 21364760 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Breast cancer | 16608533 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Malignant fibrous histiocytomas | 21085701 | CNVD |
Acute lymphoblastic leukemia | 17443227 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Melanoma | 18172304 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Colorectal cancer | 16912164 | CNVD |
Mental retardation | 17847001 | CNVD |
Melanoma | 19509136 | CNVD |
Sudden cardiac death | 19188705 | CNVD |
Prostate cancer | 16573809 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Hepatocellular carcinoma | 16785998 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Breast cancer | 21858162 | CNVD |
Breast cancer | 21785460 | CNVD |
Cancer | 22183965 | CNVD |
Melanoma | 22183965 | CNVD |
Cancer | 20164920 | CNVD |
Obesity | 20622171 | CNVD |
Breast cancer | 22522925 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Cancer | 20164919 | CNVD |
Developmental delay | 21147756 | CNVD |
Bipolar disorder | 19114987 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr11:83683800-83692000 | Weak transcription | Brain Dorsolateral Prefrontal Cortex | brain |
2 | chr11:83684000-83690400 | Weak transcription | Brain Hippocampus Middle | brain |
3 | chr11:83684000-83690600 | Weak transcription | Brain Substantia Nigra | brain |
4 | chr11:83686400-83688600 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
5 | chr11:83686800-83688400 | Enhancers | Cortex derived primary cultured neurospheres | brain |
6 | chr11:83686800-83688600 | Enhancers | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
7 | chr11:83687000-83688400 | Enhancers | Brain Anterior Caudate | brain |
8 | chr11:83687400-83690600 | Weak transcription | Ganglion Eminence derived primary cultured neurospheres | brain |
9 | chr11:83687600-83690600 | Weak transcription | Brain Cingulate Gyrus | brain |
10 | chr11:83687600-83690600 | Weak transcription | Brain Inferior Temporal Lobe | brain |
11 | chr11:83687600-83693000 | Weak transcription | Brain Angular Gyrus | brain |
12 | chr11:83688400-83689000 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
13 | chr11:83688400-83692000 | Weak transcription | Brain Anterior Caudate | brain |
14 | chr11:83688600-83689800 | Weak transcription | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
15 | chr11:83688600-83690400 | Weak transcription | H9 Derived Neuron Cultured Cells | ES cell derived |